BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:APL-4098 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of APL-4098\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06372717-2912@assetmemo.bio
DTSTAMP:20261121T005406Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:APL-4098: Phase 1 readout est. (NCT06372717)
DESCRIPTION:APL-4098\, phase 1\, Acute Myeloid Leukemia.\nStudy: A Study to
  Investigate APL-4098 Alone and in Combination in Adults With AML or MDS\n
 Estimated primary completion: July 2027. This is a ClinicalTrials.gov esti
 mate\, not a confirmed readout date\, and it can move.\nDrug page: https:/
 /assetmemo.bio/drug/apl-4098#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT06372717
URL:https://assetmemo.bio/drug/apl-4098#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
